Targeted therapies exploit the unique molecular features of cancer cells. They can block the action of molecules that drive cancer growth, induce cell death, or prevent the formation of blood vessels that supply nutrients to tumors. For example, some drugs inhibit the activity of kinases, which are enzymes that promote cell division. Others target receptors on the surface of cancer cells, blocking the signals that stimulate cancer growth.
